11456 Federal Register / Vol. 80, No. 41 / Tuesday, March 3, 2015 / Notices 

Administration, 10903 New Hampshire 

Ave., Silver Spring, MD 20993– 

0002,Telephone: 301–796–1732, FAX: 

301–796–9858, denise.picabranco@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: The first 

day of the workshop will focus on 

approaches for assessing the efficacy of 

therapeutic products on neurocognitive 

outcomes in patients diagnosed with 

inborn errors of metabolism disorders. 

The session will address the role of 

natural history studies and 

methodological approaches for selecting 

appropriate assessment scales and 

standardizing neurocognitive 

assessments. The second day of the 

workshop will discuss identification of 

signals in animal studies and clinical 

trials that warrant further clinical 

investigation and testing that may be 

predictive of neurocognitive outcome in 

children. Additionally, strategies and 

methods to address the challenges of 

assessing long-term neurocognitive 

outcomes for products used to treat 

pediatric patients will be discussed. 

Participation in the Public Workshop 

Registration: There is no fee to attend 

the public workshop, but attendees 

should register in advance. Space is 

limited, and registration will be on a 

first-come, first-served basis. Persons 

interested in attending this workshop 

must register online at neurocognitive_

workshop@fda.hhs.gov before March 31, 

2015. For those without Internet access, 

please contact Denise Pica-Branco (see 

FOR FURTHER INFORMATION CONTACT) to 

register. Onsite registration will not be 

available. 

If you need special accommodations 

due to a disability, please contact 

Denise Pica-Branco (see FOR FURTHER

INFORMATION CONTACT) at least 7 days in 

advance. 

Transcripts: Transcripts of the 

workshop will be available for review at 

the Division of Dockets Management 

(HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852, and at 

http://www.regulations.gov 

approximately 30 days after the 

workshop. A transcript will also be 

available in either hard copy or on CD– 

ROM, after submission of a Freedom of 

Information request. Send written 

requests to the Division of Freedom of 

Information (ELEM–1029), Food and 

Drug Administration, 12420 Parklawn 

Dr., Element Bldg., Rockville, MD 

20857. Send faxed requests to 301–827– 

9267. 

Dated: February 24, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–04376 Filed 3–2–15; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Immunobiology of 

Xenotransplantation (U01, U19). 

Date: March 23–24, 2015. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Room 

3F100, 5601 Fishers Lane, Rockville, MD 

20892, (Telephone Conference Call). 

Contact Person: Nancy VazquezMaldonado, Ph.D., Scientific Review Officer, 

Scientific Review Program, DEA/NIAID/NIH/ 

DHHS, 6700B Rockledge Drive, MSC–7616, 

Bethesda, MD 20892–7616, 301–496–3253, 

nvazquez@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Mucosal Environment and 

HIV Prevention (MEHP II (R01)). 

Date: March 23–24, 2015. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Room 

3C100, 5601 Fishers Lane, Rockville, MD 

20892, (Telephone Conference Call). 

Contact Person: Kelly Y. Poe, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, DEA/NIAID/NIH/DHHS, 5601 

Fishers Lane, Rockville, MD 20892, 240–669– 

5036, Kelly.poe@nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Innovative Assays to 

Quantify the Latent HIV Reservoir (R01). 

Date: March 26, 2015. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Room 

4F100, 5601 Fishers Lane, Rockville, MD 

20892. 

Contact Person: Jay R Radke, Ph.D., AIDS 

Review Branch, Scientific Review Program, 

DEA/NIAID/NIH/DHHS, Room 3G11B, 5601 

Fishers Lane, Rockville, MD 20892, 240–669– 

5046, jay.radke@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: February 25, 2015. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–04328 Filed 3–2–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Program 

Project: Structure/Function studies of 

Secondary Transporters in a Lipid 

Environment. 

Date: March 23–25, 2015. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Albert Wang, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 4146, MSC 7806, Bethesda, MD 

20892, 301–435–1016, wangca@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: AIDS and AIDS Related Research. 

Date: March 24–25, 2015. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 41 / Tuesday, March 3, 2015 / Notices 11457 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Kenneth A. Roebuck, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5106, 

MSC 7852, Bethesda, MD 20892, (301) 435– 

1166, roebuckk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Autoimmune Diseases. 

Date: March 24, 2015. 

Time: 1:00 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Rajiv Kumar, Ph.D., Chief, 

MOSS IRG, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 4216, MSC 7802, Bethesda, MD 

20892, 301–435–1212, kumarra@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Program 

Project: Biological Labeling Neutrons and 

Computing Resource. 

Date: March 24–26, 2015. 

Time: 8:00 p.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Oak Ridge National Laboratory, 8640 

Nano Center Drive, Oak Ridge, TN 37831. 

Contact Person: Mike Radtke, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4176, 

MSC 7806, Bethesda, MD 20892, 301–435– 

1728, radtkem@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Fellowship: 

Physiology and Pathobiology of 

Musculoskeletal, Oral, and Skin Systems. 

Date: March 25, 2015. 

Time: 8:00 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Anshumali Chaudhari, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4124, 

MSC 7802, Bethesda, MD 20892, (301) 435– 

1210, chaudhaa@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Cognition and Perception. 

Date: March 25, 2015. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Biao Tian, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3089B, MSC 7848, Bethesda, 

MD 20892, (301) 402–4411, tianbi@

csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Biological Chemistry and 

Macromolecular Biophysics. 

Date: March 26, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Michael Eissenstat, Ph.D., 

Scientific Review Officer, BCMB IRG, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4166, 

Bethesda, MD 20892, 301–435–1722, 

eissenstatma@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Oncology. 

Date: March 26–27, 2015. 

Time: 10:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Juraj Bies, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Dr., Rm. 4205, MSC 7806, Bethesda, MD 

20892, 301–435–1258, biesj@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Multidisciplinary Studies of HIV/AIDS and 

Aging. 

Date: March 26, 2015. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Robert Freund, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5216, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1050, freundr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; National 

Primate Research Centers Application. 

Date: March 27, 2015. 

Time: 2:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Biao Tian, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3089B, MSC 7848, Bethesda, 

MD 20892, (301) 402–4411, tianbi@

csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 25, 2015. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–04323 Filed 3–2–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; AIDS Research Review 

Committee Independent Special Emphasis 

Panel. 

Date: March 24, 2015. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Vasundhara Varthakavi, 

DVM, Ph.D., Scientific Review Officer, 

Scientific Review Program, DEA/NIAID/NIH/ 

DHHS, 5601 Fishers Lane, Rockville, MD 

20892, 240–669–5020, varthakaviv@

niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: February 25, 2015. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–04326 Filed 3–2–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

mstockstill on DSK4VPTVN1PROD with NOTICES